Data and Results from Collaborations to be Presented at AGBT; Company Announces 13 New Members of Partner Program
"We are entering the later stages of our limited production release
(LPR) program, and have begun upgrading the beta instruments to the
commercial hardware configurations," said
Data generated using the PacBio RS system by early collaborators
and customers as well as Pacific Biosciences scientists will be
presented in eleven posters, four scientific sessions, and during the
company's commercial workshop at AGBT. Highlights of work completed as
part of the Partner Program include a collaboration with RainDance
Technologies and the
"In my lab we are characterizing HIV splice variants to understand
mechanisms of viral replication," said
"Infectious disease research is a key application that stands to benefit
from the advantages of the PacBio RS system," commented
"Whether it is for monitoring drug resistance in Hepatitis C or AIDS patients, elucidating the cloud of virus that exists in patient samples, or real-time monitoring of pathogens over broad geographic regions to predict outbreaks, Single Molecule Real Time (SMRT™) sequencing enables a new era of molecular epidemiology," he added.
First announced in conjunction with last year's AGBT conference, the Pacific Biosciences Partner Program has continued to evolve to span key synergistic areas of the PacBio RS sequencing workflow including consumables, automation systems, complementary instrumentation, services and supporting software and hardware. The company announced the following new partners:
-
Automation and microfluidics:
Beckman Coulter ,Hamilton Company , andTecan Group Ltd. - Shearing and fragmentation: Covaris, Diagenode, Digilab, and Microsonic Systems
- Size selection: Sage Science
-
Data analysis and cloud computing:
Biomatters Limited , DNAnexus, DNASTAR, Galaxy, andGenomatix Software
As an example of a solution created using the application programming
interfaces (APIs) available through PacBio's Developer's Network
(DevNet), Anton Nekrutenko, Ph.D. from
A description of the Partner Program and full list of companies participating can be found on the PacBio website: http://www.pacificbiosciences.com/community/partner_program. More information about the company's activities at this week's AGBT conference can be found at http://pacificbiosciences.com/AGBT2011/.
About Pacific Biosciences
Pacific Biosciences' mission is to transform the way humankind acquires,
processes and interprets data from living systems through the design,
development and commercialization of innovative tools for biological
research. The company has developed a novel approach to studying the
synthesis and regulation of DNA, RNA and proteins. Combining recent
advances in nanofabrication, biochemistry, molecular biology, surface
chemistry and optics, Pacific Biosciences has created a powerful
technology platform called single molecule, real-time, or SMRT™,
technology.
This press release contains forward-looking statements relating to our
plans to continue to optimize the chemistry, perform verification, and
validation of the system, and provide software upgrades and to begin
shipping in the first half of this year. Forward-looking statements may
contain words such as "believe," "may," "estimate," "anticipate,"
"continue," "intend," "expect," "plan," the negative of these terms, or
other similar expressions, and include the assumptions that underlie
such statements. These statements are subject to known and unknown risks
and uncertainties that could cause actual results to differ materially
from those expressed or implied by such statements, including but not
limited to risks discussed from time to time in documents we have filed
with the
Media:
For Pacific Biosciences
nicole@bioscribe.com
or
Investors:
Pacific
Biosciences
ir@pacificbiosciences.com
Source:
News Provided by Acquire Media